Different evaluation measures assess different characteristics of machine learning algorithms. The empirical evaluation of algorithms and classifiers is a matter of on-going debate between researchers. Although most measures in use today focus on a classifier's ability to identify classes correctly, we suggest that, in certain cases, other properties, such as failure avoidance or class discrimination may also be useful. We suggest the application of measures which evaluate such properties. These measures -Youden's index, likelihood, Discriminant power -are used in medical diagnosis. We show that these measures are interrelated, and we apply them to a case study from the field of electronic negotiations. We also list other learning problems which may benefit from the application of the proposed measures.
Abstract. Support Vector Machines (SVM) have been extensively studied and have shown remarkable success in many applications. However the success of SVM is very limited when it is applied to the problem of learning from imbalanced datasets in which negative instances heavily outnumber the positive instances (e.g. in gene profiling and detecting credit card fraud). This paper discusses the factors behind this failure and explains why the common strategy of undersampling the training data may not be the best choice for SVM. We then propose an algorithm for overcoming these problems which is based on a variant of the SMOTE algorithm by Chawla et al, combined with Veropoulos et al's different error costs algorithm. We compare the performance of our algorithm against these two algorithms, along with undersampling and regular SVM and show that our algorithm outperforms all of them.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.